Eli Lilly and Company (NYSE: LLY) and Egypt-headquartered EVA Pharma have developed a plan to collaborate to supply at least one million people in low- and middle-income countries. Many of the recipients of the vaccines will be in Africa.  Roughly a month ago, Lilly’s share price fell about 4% after a fake Twitter account stated…